AGIO — AGIOS PHARMACEUTICALS INC

Ownership history in GUGGENHEIM CAPITAL LLC  ·  30 quarters on record

This page tracks every 13F SEC filing in which GUGGENHEIM CAPITAL LLC reported a position in AGIOS PHARMACEUTICALS INC (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2015 Q2)
Avg. % of fund
0.01%
First filed
2014 Q2
Last filed
2025 Q3
Quarters held
30
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 15,902 -2,002 -11.2% 0.00% $638K $40.14
2025 Q2 REDUCED 17,904 -851 -4.5% 0.00% $595K $33.26
2025 Q1 ADDED 18,755 +5,052 +36.9% 0.01% $550K $29.30
2024 Q4 REDUCED 13,703 -35,827 -72.3% 0.00% $450K $32.86
26 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AGIO price (monthly, adj. close)

Other funds also holding AGIO

As of 2025 Q4 — sorted by position size

MPM BioImpact LLC 3Y 4.06% Exome Asset Management LLC 1.78% Rock Springs Capital Management LP 3Y 7Y 1.12% TCG Crossover Management, LLC 3Y 1.06% HighVista Strategies LLC 3Y 7Y 1.04% ARMISTICE CAPITAL, LLC 3Y 7Y 0.98% ARMISTICE CAPITAL, LLC 3Y 7Y 0.97% Frazier Life Sciences Management, L.P. 3Y 0.94% Tetragon Partners GP Ltd 3Y 7Y 0.93% Palo Alto Investors LP 3Y 7Y 0.81%
← Back to GUGGENHEIM CAPITAL LLC Holdings